CTMX Varseta-M reports robust late-line CRC efficacy
TradingView reports a conference highlighted strong clinical progress for Varseta-M in late-line colorectal cancer, with promising efficacy and safety, plus a pivotal study planned for next year.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.